Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @GreenphireINC
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @GreenphireINC
-
We are excited to be heading north! Come see us at the
#N2Annual Meeting in Toronto@N2Canada#ClinicalTrials#ClinicalResearchpic.twitter.com/CpzyhJmgH5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Greenphire proslijedio/la je Tweet
Regional differences in processes & regulations compound the challenges of 21st century clinical trial management. Is it time for standardisation on its way, and what can we do in the meantime?
@pharmaphorum@GreenphireINChttps://pharmaphorum.com/r-d/views-analysis-r-d/bridging-the-gap-between-global-trials-and-regional-processes/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you
@LazarexCF@DanaDornsife@LazarexaErin for all that you do for patients worldwide.#WorldCancerDay
https://twitter.com/LazarexCF/status/1224784884952006656 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cost and logistics should never be a deterrent for patients who wish to participate in clinical trials - especially not those taking part in groundbreaking cancer research. Read today's guest blog by
@worldwidetrials: http://bit.ly/398HTzT#WorldCancerDay
#PatientCentricitypic.twitter.com/TFo6gWFRwZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New video series! In this clip, Jim Murphy, CEO, and Kyle Cunningham, CPO, discuss how their own travel challenges have helped them to better understand the patient journey in
#clinicaltrials. Learn more about ConneX: https://greenphire.com/connex/#patientcentricitypic.twitter.com/GZaxMv1hgKHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Attending
#PatientRecruitment#PatientRetention this week? We'd love to meet you! Stop by the Greenphire booth to learn how our commitment to#PatientConvenience is easing site and participant burdens.@AllanLloyds#ClinicalTrials#ClinicalResearchpic.twitter.com/7CaSboTmdT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Greenphire team had a great time at the
@MySCRS#SCRS20Oncology this weekend in Austin! http://bit.ly/37UUGG7#patientconvenience#patientcentricitypic.twitter.com/0nG7TamsEp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are headed to London for the 12th annual Patient Recruitment and Retention Summit. Hope to see you there!
@AllanLloyds#PatientRecruitment#PatientRetention#PatientCentric#PatientConvenience#ClinicalTrialspic.twitter.com/BdWOx7TbecHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are in Austin for
#SCRS20Oncology. Make sure to stop by and meet Beth and Brian to learn how Greenphire can help ease your site, as well as participant, burdens.@MySCRS#OncologyStudy#ClinicalResearchpic.twitter.com/5ofFXPjTYI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What are you doing for
#FunAtWorkDay 2020??? We're starting our "big game" celebrations early!#WingFest2020#GreenphireLife#PhiredUppic.twitter.com/PJskrhQjug
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
At
#SCRS20Oncology in Austin? Make sure to join Greenphire CEO Jim Murphy and@LazarexCF Chairman of the Board Dana Dornsife as they discuss removing financial and logistical burdens from oncology#clinicaltrial participants.#OncologyTrials#ClinicalResearchpic.twitter.com/IYs4ce1bAa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Going to
#SCRS20Oncology? Make sure you stop by our booth to learn more about how Greenphire is helping to ease logistical burdens for oncology patients worldwide.@MySCRS#ClinicalTrials#OncologyTrials#ClinicalResearchpic.twitter.com/qXnJLgvv70Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We want to hear from you! What are the barriers that patients face when enrolled in a clinical trial? How can we overcome these hurdles? Join other Sites, Sponsors and CROs in sharing what patient convenience means to you in this new Greenphire survey. http://bit.ly/2vuBIYr pic.twitter.com/1T1ESTL1EG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Great article on
#clinicaltrial patient and site engagement@Pharma_Intell &@ICONplc:https://scrip.pharmaintelligence.informa.com/SC141510/Rethinking-Patient-And-Site-Engagement …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As cited in
@worldpharma2day, Greenphire expands our#patienttravel#patientconvenience solution - ConneX. Learn more: http://bit.ly/2RLjVUqHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meet some of our Greenphire friendly faces and hear how our expanded
#ConneX#clinicaltrial travel solution can give your patients peace of mind: http://bit.ly/38sEsDJ pic.twitter.com/ur6GtxnsKrHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Greenphire proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
ConneX was created to eliminate the logistical & financial barriers that impact
#clinicaltrial patients & site staff. Read how we've expanded our solution: http://bit.ly/3au3cgX#patientconvenience#patienttravelpic.twitter.com/1r6XA2wGD9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Greenphire proslijedio/la je Tweet
SCRS GIP
@GreenphireINC Expands ConneX Global Travel Solution to Further Support Clinical Trial Participation and Retention Worldwide. Read more here:http://ow.ly/LtX450xZXTZHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
